SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 fourth quarter and full year ended September 30, 2023, before the…
Click here to view original post
Copyright © 2023 Biotech Networks, LLC
